Drawing for RYSEZRA

USPTO serial 99791630

RYSEZRA

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
FATHY, DOMINIC
Law office
TMEG LAW OFFICE 104

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RYSEZRA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Elsa D. Lemoine

Elsa D. Lemoine Amgen Inc.One Amgen Center DriveThousand Oaks, CA 91320-1799United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of autoimmune, inflammatory, and immune-mediated diseases and disorders; Pharmaceutical preparations for the treatment of diseases and conditions of the immune system; Pharmaceutical preparations for the treatment of Sjögren’s syndrome and related conditions; Pharmaceutical preparations for the treatment of dryness of the eyes and mouth; Pharmaceutical preparationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 14, 2026MAB1ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT—
Nov 14, 2026ABN1ABANDONMENT - EXPRESS MAILED—
Nov 13, 2026EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Jul 27, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jul 27, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Jul 25, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 25, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 25, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 23, 2026DOCKASSIGNED TO EXAMINER—
Apr 28, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 28, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 28, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance